This drug may increase heart rate, PVCs and nonsustained ventricular tachycardia.
Do not take this drug if symptoms of congestive heart failure (e.g., shortness of breath, swelling of the legs) are present.
Cardiovascular risk may observe during long-term use of this drug.
Use in patient with a history of hypersensitivity to any ingredient of the drug is contraindicated.
Breast-feeding is not recommended because of possible unwanted effects in nursing infants.
This drug should not be administered to patients with cerebral infarction until their condition has stabilized.
When cilostazol is administered to patients with cerebral infarction, administration should be performed with caution for possible interaction with other drugs, such as antiplatelet drugs. In cerebral infarction with high blood pressure, blood pressure should be sufficiently controlled during cilostazol treatment.
Other Services
Country
Account